日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma

基于机器学习的滤泡性淋巴瘤POD24预测模型：中国滤泡性淋巴瘤研讨会的一项研究

期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-024-00716-4
Zha, Jie; Chen, Qinwei; Zhang, Wei; Jing, Hongmei; Ye, Jingjing; Liu, Huanhuan; Yu, Haifeng; Yi, Shuhua; Li, Caixia; Zheng, Zhong; Xu, Wei; Li, Zhifeng; Lin, Zhijuan; Ping, Lingyan; He, Xiaohua; Zhang, Liling; Xie, Ying; Chen, Feili; Sun, Xiuhua; Su, Liping; Zhang, Huilai; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing
淋巴瘤
发表日期：2025
文献解析 文献求助 收藏

Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study

3a级和1-2级滤泡性淋巴瘤患者临床特征和预后的差异：一项真实世界多中心研究

期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-023-00462-z
Zha, Jie; Chen, Qinwei; Ye, Jingjing; Yu, Haifeng; Yi, Shuhua; Zheng, Zhong; Xu, Wei; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Zhang, Liling; Li, Caixia; Xie, Ying; Chen, Feili; Sun, Xiuhua; Su, Liping; Zhang, Huilai; Fan, Liyuan; Lin, Zhijuan; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing
淋巴瘤
发表日期：2023
文献解析 文献求助 收藏

Dual targeting of PI3Kδ and PPARα enhances antitumor activity via FoxO1 activation in follicular lymphoma.

PI3Kα和PPARα双重靶向可通过FoxO1激活增强滤泡性淋巴瘤的抗肿瘤活性。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-026-08593-5
Wang Wenqin, Zhou Hui, Tan Shuangxiong, Qin Dongmei, Wang Shuxuan, Xu Chunlan, Lei Xiangru, Li Wenjuan, Wang Liangjie, Fu Shuhui, Jia Shuman, Xu Bing, Zha Jie
肿瘤
淋巴瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Dual epigenetic and nuclear export inhibition by chidamide and selinexor in high grade B-cell lymphomas via survivin and PI3K/AKT inhibition.

西达米酮和塞利尼索通过抑制survivin和PI3K/AKT，对高级别B细胞淋巴瘤产生双重表观遗传和核输出抑制作用。

期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-026-02056-6
Lin Jiazhen, Zhuang Xinguo, Jia Shuman, Zhou Hui, Qin Dongmei, Zhou Jie, Chen Bozhang, Zhuang Mingxin, Xu Bing, Zha Jie
淋巴瘤
细胞生物学
B细胞
AKT
Survivin
PI3K/Akt
发表日期：2026
文献求助 收藏

Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer

基线D-二聚体作为癌症免疫检查点抑制剂疗效的预测指标

期刊:
影响因子:
doi:10.1080/07853890.2026.2620195
Li, Fan; Zha, Jie; Hu, Meimei; Zhang, Wei
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Combination of HDAC inhibitor and PI3K inhibitor suppresses autophagy and induces apoptosis via cytoplasmic IκBα stabilization in p53-mutant diffuse large B-cell lymphoma.

HDAC 抑制剂和 PI3K 抑制剂的组合通过胞质 Iββ 稳定抑制自噬并诱导 p53 突变弥漫性大 B 细胞淋巴瘤细胞凋亡

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02756-7
Yao Jingwei, Li Mengqi, Jiang Yuelong, Yao Nanye, Liu Yating, Lv Liemei, Li Yuchen, Huang Jiewen, Zha Jie, Xu Bing
细胞生物学
P53
凋亡
自噬
发表日期：2025
文献求助 收藏

Visual detection of Coxsackievirus A6 using a reverse transcription polymerase spiral reaction method

利用逆转录聚合酶螺旋反应法进行柯萨奇病毒A6的目视检测

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.6
doi:10.3389/fcimb.2025.1563495
Kun Wang #,Yuanhang Ai #,Juan Luo #,Longying Liang,Weiwei Zhang,Guojun Cao,He Zha,Jie Wu,Kun Lei,Shifei Yao,Kaifeng Wu
毒理研究
发表日期：2025
文献求助 收藏

Venetoclax confers synthetic lethality to chidamide in preclinical models with transformed follicular lymphoma.

在转化型滤泡性淋巴瘤的临床前模型中，维奈托克可赋予西达米德合成致死性

期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-025-01878-0
Zhong Mengya, Pan Guangchao, Tan Jinshui, Yao Jingwei, Liu Yating, Huang Jiewen, Jiang Yuelong, Zhu Depeng, Zhao Jintao, Xu Bing, Zha Jie
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Chidamide and anlotinib synergistically inhibit high grade B-cell lymphomas via PI3K/AKT signaling pathway.

西达米德和安罗替尼通过PI3K/AKT信号通路协同抑制高级别B细胞淋巴瘤

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-10334-1
Lin Jiazhen, Zhuang Xinguo, Jia Shuman, Zhou Hui, Qin Dongmei, Zhou Jie, Luo Yiming, Xu Bing, Zha Jie
细胞生物学
PI3K/Akt
发表日期：2025
文献求助 收藏

DGKα inhibition enhances the antitumor effect of chiauranib on transformed follicular lymphoma.

DGKα抑制增强了chiauranib对转化型滤泡性淋巴瘤的抗肿瘤作用。

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06636-z
Huang Jiewen, Zhong Mengya, Yao Jingwei, Pan Guangchao, Chen Qinwei, Liu Yating, Jiang Yuelong, Luo Yiming, Zha Jie, Xu Bing
肿瘤
淋巴瘤
肿瘤免疫
发表日期：2025
文献求助 收藏